AIM AND SCOPE

The Journal of Obesity and Metabolic Diseases aims to serve as a comprehensive international platform for the publication of high-quality research, clinical studies, and scholarly contributions in the fields of obesity, metabolism, endocrinology, and related therapeutic sciences. The journal is dedicated to advancing scientific understanding of obesity and metabolic disorders, improving diagnostic and preventive strategies, and promoting the development of innovative therapeutic approaches for metabolic health conditions affecting individuals across all age groups.

The journal seeks to bridge the gap between basic biomedical research and clinical application by encouraging translational, interdisciplinary, and evidence-based studies that contribute to improved patient care, disease prevention, and public health outcomes. Special emphasis is placed on research that enhances understanding of the biological, genetic, environmental, behavioral, and socio-economic factors influencing obesity and metabolic diseases.

The journal also aims to foster collaboration among researchers, clinicians, healthcare professionals, nutritionists, endocrinologists, public health experts, and academicians worldwide, enabling the exchange of scientific knowledge and advancements in metabolic medicine. Emphasis is placed on scientific rigor, ethical research practices, and the dissemination of findings that have significant clinical, societal, and global health impact.

Scope of the Journal

The journal covers a broad range of topics related to obesity, metabolism, endocrinology, nutrition, and metabolic therapeutics. The primary areas of interest include, but are not limited to, the following:

Obesity research, childhood obesity, adolescent obesity, adult obesity, morbid obesity, abdominal obesity, metabolic syndrome, insulin resistance, type 1 diabetes, type 2 diabetes, gestational diabetes, prediabetes, dyslipidemia, hyperlipidemia, hypertension associated with obesity, cardiovascular complications of obesity, endocrine disorders, hormonal regulation of metabolism, thyroid disorders, adrenal disorders, pituitary disorders, polycystic ovary syndrome, fatty liver disease, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, bariatric medicine, bariatric surgery, metabolic surgery, obesity-related cancers, inflammatory pathways in obesity, adipose tissue biology, lipid metabolism, glucose metabolism, energy balance, appetite regulation, gut microbiota, gut-brain axis, metabolic inflammation, oxidative stress, mitochondrial dysfunction, nutritional biochemistry, micronutrient deficiencies, dietary interventions, clinical nutrition, medical nutrition therapy, ketogenic diets, low-carbohydrate diets, intermittent fasting, lifestyle modification, exercise physiology, physical activity interventions, weight management programs, obesity prevention strategies, public health nutrition, community health interventions, behavioral therapy, psychological aspects of obesity, eating disorders, sleep and metabolism, circadian rhythm disorders, pediatric metabolic diseases, aging and metabolism, women’s metabolic health, men’s metabolic health, reproductive endocrinology, obesity genetics, epigenetics in metabolic diseases, nutrigenomics, metabolomics, proteomics, systems biology, bioinformatics in metabolic research, artificial intelligence in metabolic medicine, machine learning in obesity prediction, biomarkers of metabolic disease, molecular diagnostics, precision medicine, personalized nutrition, pharmacotherapy for obesity, anti-obesity drugs, diabetes therapeutics, endocrine therapeutics, regenerative medicine, stem cell research in metabolism, translational medicine, clinical trials, epidemiology of obesity, population health studies, healthcare disparities in obesity care, socioeconomic determinants of metabolic diseases, occupational and environmental influences on metabolism, health policy, preventive medicine, rehabilitation in metabolic disorders, telemedicine in obesity management, digital health technologies, wearable devices, mobile health applications, patient education, healthcare delivery systems, ethical issues in obesity research, policy and regulation in metabolic healthcare, and emerging technologies in obesity and metabolic disease research.

Types of Manuscripts

The journal accepts a variety of manuscript types including original research articles, review articles, systematic reviews, meta-analyses, case reports, case series, short communications, technical notes, clinical studies, editorials, perspectives, and letters to the editor.

The topics listed above represent the primary areas of interest of the journal; however, the scope is not limited to these main topics. The journal welcomes submissions from emerging, interdisciplinary, and innovative areas that contribute to the understanding, diagnosis, prevention, and treatment of obesity and metabolic diseases.

Global Perspective and Inclusivity

The journal adopts a global perspective by encouraging submissions from researchers and clinicians across diverse geographic regions. Obesity and metabolic diseases represent major global health challenges, with prevalence and clinical outcomes varying across populations due to genetic, environmental, cultural, and socio-economic factors.

By promoting international collaboration, the journal seeks to address worldwide health concerns and reduce disparities in access to diagnosis, prevention, and treatment. Studies highlighting regional trends, population-specific findings, and public health approaches are particularly valuable in broadening the understanding of obesity and metabolic disorders on a global scale.

Ethical, Legal, and Social Considerations

Research involving obesity and metabolic diseases often raises important ethical, legal, and social considerations. The journal recognizes the importance of responsible research practices and encourages scholarly work addressing patient rights, healthcare accessibility, stigma reduction, and ethical clinical management.

Topics such as informed consent, patient privacy, data protection, equitable healthcare access, obesity-related discrimination, and responsible use of emerging technologies are integral to the ethical framework of the journal. Authors are expected to adhere to established ethical guidelines and maintain the dignity and welfare of study participants and patient communities.

Education and Knowledge Dissemination

The journal is committed to advancing education and knowledge dissemination in the fields of obesity and metabolic diseases. It aims to serve as a valuable resource for students, educators, clinicians, researchers, nutritionists, and healthcare professionals by publishing high-quality, informative, and impactful scientific content.

Educational reviews, clinical updates, and practical guidance articles that simplify complex metabolic concepts and improve clinical understanding are highly encouraged. Through continuous learning and professional development, the journal contributes to building a knowledgeable scientific and healthcare community.

Quality, Integrity, and Scientific Rigor

Maintaining high standards of quality and integrity is a central principle of the journal. All submissions are expected to demonstrate scientific rigor, methodological soundness, originality, and clarity of presentation. The journal supports ethical research practices and ensures that all published work adheres to internationally recognized scientific and publication standards.

The peer review process is designed to provide thorough, unbiased, and constructive evaluation of manuscripts. Authors are encouraged to present their findings transparently and accurately, contributing to the reliability and credibility of scientific literature in obesity and metabolic research.

Encouragement of Collaborative Research

The journal promotes collaborative and multidisciplinary research efforts involving clinicians, endocrinologists, nutrition experts, surgeons, epidemiologists, psychologists, geneticists, public health professionals, and biomedical researchers. Collaborative studies often lead to innovative solutions and more comprehensive understanding of complex metabolic disorders.

By providing a platform for interdisciplinary cooperation, the journal aims to strengthen research quality and accelerate scientific progress. Contributions resulting from national and international collaborations are strongly encouraged.

Adaptability to Advancing Science

The fields of obesity and metabolic medicine are rapidly evolving with continuous advancements in biotechnology, therapeutics, genomics, digital health, and precision medicine. The journal remains adaptable to these scientific developments by expanding its scope to include emerging research areas and innovative therapeutic strategies.

Authors are encouraged to explore novel concepts, technologies, and clinical applications that contribute to the evolving landscape of obesity and metabolic disease research. The journal is committed to staying current with scientific advancements and ensuring that its content reflects the latest progress in the field.